Pinar Demirtepe: Not All “Blood Thinners” Are the Same
Pinar Demirtepe, Intensive Care Nurse at Ministry of Health of the Republic of Türkiye, shared a post on LInkedIn:
“One of the things I learned after starting to work in the Coronary Intensive Care Unit surprised me.
Many people, including healthcare professionals early in their careers, use the term ‘blood thinner’ for different medications. However, anticoagulants and antiplatelet drugs are not the same.
Anticoagulants mainly target the coagulation cascade and help prevent fibrin-rich clots, while antiplatelet drugs reduce platelet aggregation and are particularly important in arterial thrombosis, such as coronary artery disease.
Understanding the mechanism behind these medications is far more valuable than simply memorizing their names.
Every day in critical care reminds me how much there is still to learn—and that’s one of the things I enjoy most about this profession.”
Stay updated with Hemostasis Today.
-
Jun 28, 2026, 19:05Jack Shuang Hou: Novo Nordisk to Present New Haemophilia Data on Investigational Denecimig at ISTH 2026
-
Jun 28, 2026, 19:05Andrea Cesari: Comparing Catheter-Based Reperfusion Strategies for Intermediate-High-Risk PE
-
Jun 28, 2026, 19:02Nassim Emteir: Interpreting TSAT with Ferritin to Guide Iron Deficiency Diagnosis and Treatment
-
Jun 28, 2026, 19:00Andrew Jackson: Predicting PICC-Related Venous Thrombosis in Patients Undergoing Radiotherapy
-
Jun 28, 2026, 10:34Heghine Khachatryan: Menarche as the First ‘Bleeding Challenge’
-
Jun 28, 2026, 10:13Mohammed Alharbi: Assessing Warfarin Management and Anticoagulation Quality in Older Populations
-
Jun 28, 2026, 10:03Rick Kapur: Current Understanding of FNAIT Regarding Diagnostics, Pathophysiology and Management
-
Jun 28, 2026, 09:55Utkarsh Pandey: Japan Approves Wayrilz for ITP Patients
-
Jun 28, 2026, 09:41Sung-mok Jung: How Environmental Drivers Influence SFTS Occurrence